Results 101 to 110 of about 277,634 (194)

PND61 LITERATURE REVIEW ON THE POTENTIAL SOCIETAL IMPACT OF DISEASE-MODIFYING THERAPIES IN ALZHEIMER€™S DISEASE [PDF]

Value in Health, 2019
T. Mantopoulos, T. Dort, G. Spentzouris, C. Quinn, R. Thompson, H. Wieffer   +5 more
openaire   +2 more sources

Additional file 5: of Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimerâ s disease

, 2019
Figure S1. Quantitative abundances of the proteins involved in mitochondrial fusion and fission and mitoribosomes in brain proteomes of early onset AD (log2 (115/114)), late onset AD (log2 (117/116)) and healthy aging subjects (log2 (116/114)). A) iTRAQ quantitative ratios of proteins involved in mitochondrial fusion and fission, B) and C) iTRAQ ...
Adav, Sunil, Park, Jung, Siu Sze
openaire   +1 more source

PND64 TRENDS AND DISPARITIES IN PHARMACEUTICAL TREATMENT FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA PATIENTS [PDF]

Value in Health, 2019
Emmanuel F Drabo, Patricia Ferido, Geoffrey F. Joyce, Julie Zissimopoulos, Douglas Barthold   +4 more
openaire   +2 more sources

Additional file 1: of Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimerâ s disease

, 2019
Table S1. Participantsâ family mutations. (DOCX 17 kb)
Weston, Philip, Poole, Teresa, O’Connor, Antoinette, Heslegrave, Amanda, Ryan, Natalie, Liang, Yuying, Druyeh, Ronald, Mead, Simon, Blennow, Kaj, Schott, Jonathan, Frost, Chris, Zetterberg, Henrik, Fox, Nick   +12 more
openaire   +1 more source

Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones

Nature Communications, 2018
Munc18-1 is an evolutionary conserved gene whose mutations are linked to various neurological diseases in human. In order to better understand the exact nature of the mutations, the authors here utilize several model systems to show mutant Munc18-1 can ...
Noah Guy Lewis Guiberson, André Pineda, Debra Abramov, Parinati Kharel, Kathryn E. Carnazza, Rachel T. Wragg, Jeremy S. Dittman, Jacqueline Burré   +7 more
doaj   +1 more source

A Review on Nanotechnology in Diagnosis and Treatment of Alzheimer’s Disease

American Journal of PharmTech Research, 2018
Venkateswara Rao. S, Padmalatha. K, Sravya. K   +2 more
openaire   +1 more source

MOESM1 of Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype

, 2019
Additional file 1: Table S1. Systematic literature search for AD proteomics studies.
Hesse, Raphael, Maica Hurtado, Jackson, Rosemary, Eaton, Samantha, Herrmann, Abigail, Colom-Cadena, Marti, Makis Tzioras, King, Declan, Rose, Jamie, Tulloch, Jane, Chris-Anne McKenzie, Smith, Colin, Henstridge, Christopher, Lamont, Douglas, Wishart, Thomas, Spires-Jones, Tara   +15 more
openaire   +1 more source

Additional file 4: of Older patients are still under-represented in clinical trials of Alzheimerâ s disease

, 2016
Main characteristics of trials included in the age analyses (79). (DOCX 30 kb)
Banzi, Rita, Camaioni, Paolo, Tettamanti, Mauro, Bertele’, Vittorio, Lucca, Ugo   +4 more
openaire   +1 more source

Additional file 3: of Older patients are still under-represented in clinical trials of Alzheimerâ s disease

, 2016
List of studies included. (DOCX 34 kb)
Banzi, Rita, Camaioni, Paolo, Tettamanti, Mauro, Bertele’, Vittorio, Lucca, Ugo   +4 more
openaire   +1 more source

Additional file 1 of A novel approach for multi-SNP GWAS and its application in Alzheimerâ s disease

, 2016
Table 3. Gene pairs with SNP pairs having r 2â Ľ 0.04. (PDF 169 kb)
Bodily, Paul, M. Fujimoto, Page, Justin, Clement, Mark, Ebbert, Mark, Ridge, Perry   +5 more
openaire   +1 more source